Unveil the mysterious mask of cytokine-based immunotherapy for melanoma
作者： Dixon H. Xu , Ziwen Zhu , Huaping Xiao , Mark R. Wakefield , Qian Bai
DOI: 10.1016/J.CANLET.2017.02.022
关键词: Cytokine 、 Immunogenic tumor 、 Advanced melanoma 、 Treatment options 、 Immunology 、 Melanoma 、 Cancer research 、 Immunotherapy 、 Medicine 、 Oncology
摘要: Melanoma is the leading cause of death among all skin cancers and its incidence continues to rise rapidly worldwide in past decades. The available treatment options for melanoma remain limited despite extensive clinical research. an immunogenic tumor great advances immunology recent decades allow development immunotherapeutic agents against melanoma. In years, immunotherapy utilizing cytokines has been particularly successful certain holds promise patients with advanced this review, overview current status emerging perspectives on cytokine are discussed details. Such a study will be helpful unveil mysterious mask cytokine-based
elsevier.com
sci-hub.se 参考文章(154)
Soo-Hyun Kim, Sun-Young Han, Tania Azam, Do-Young Yoon, Charles A. Dinarello, Interleukin-32: A Cytokine and Inducer of TNFα Immunity. ,vol. 22, pp. 131- 142 ,(2005) , 10.1016/J.IMMUNI.2004.12.003
Janice P Dutcher, Lori Stover, Rowena N Schwartz, Managing toxicities of high-dose interleukin-2. Oncology. ,vol. 16, pp. 11- 20 ,(2002)
Legha Ss, The role of interferon alfa in the treatment of metastatic melanoma. Seminars in Oncology. ,vol. 24, ,(1997)
R J Armitage, H M Sassenfeld, K H Grabstein, A E Namen, Regulation of human T cell proliferation by IL-7. Journal of Immunology. ,vol. 144, pp. 938- 941 ,(1990)
M D Boyano, M D Garcia-Vázquez, T López-Michelena, J Gardeazabal, J Bilbao, M L Cañavate, A García De Galdeano, R Izu, L Díaz-Ramón, J A Raton, J L Díaz-Pérez, Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma British Journal of Cancer. ,vol. 83, pp. 847- 852 ,(2000) , 10.1054/BJOC.2000.1402
U. Keilholz, P. Martus, C.J.A. Punt, W. Kruit, G. Mooser, D. Schadendorf, D. Liénard, R. Dummer, J. Koller, C. Voit, A.M.M. Eggermont, Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: Second analysis of a randomised EORTC Melanoma Group trial comparing interferon-α2a (IFNα) and interleukin 2 (IL-2) with or without cisplatin European Journal of Cancer. ,vol. 38, pp. 1501- 1511 ,(2002) , 10.1016/S0959-8049(02)00123-5
Douglas S. Reintgen, Dewayne Ussery, Julie Y. Djeu, Ana M. Gamero, Christopher A. Puleo, Interleukin 15 Induction of Lymphokine-activated Killer Cell Function against Autologous Tumor Cells in Melanoma Patient Lymphocytes by a CD18-Dependent, Perforin-related Mechanism Cancer Research. ,vol. 55, pp. 4988- 4994 ,(1995)
Cristina Fortes, Simona Mastroeni, Thomas Manooranparanpampil, Francesca Passarelli, Alba Zappalà, Claudia Marino, Nicoletta Russo, Paola Michelozzi, Tumor-infiltrating lymphocytes predict cutaneous melanoma survival. Journal of Translational Medicine. ,vol. 13, pp. 1- 1 ,(2015) , 10.1186/1479-5876-13-S1-O9
Takayuki Yoshimoto, Noriko Morishima, Izuru Mizoguchi, Motomu Shimizu, Hiroshi Nagai, Shuntaro Oniki, Masahiro Oka, Chikako Nishigori, Junichiro Mizuguchi, Antiproliferative Activity of IL-27 on Melanoma Journal of Immunology. ,vol. 180, pp. 6527- 6535 ,(2008) , 10.4049/JIMMUNOL.180.10.6527
S. He, H. Zhang, H. Chen, H. Yang, T. Huang, Y. Chen, J. Lin, F. Wang, X. Chen, T.-L. Li, P. Yang, Expression and release of IL-29 by mast cells and modulation of mast cell behavior by IL-29. Allergy. ,vol. 65, pp. 1234- 1241 ,(2010) , 10.1111/J.1398-9995.2010.02349.X